JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by YOUNG, A. G.
Right arrow Articles by LOEVENHART, A. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by YOUNG, A. G.
Right arrow Articles by LOEVENHART, A. S.
Journal of Pharmacology And Experimental Therapeutics, Vol. 23, Issue 2, 107-126, 1924
Copyright © 1924 by American Society for Pharmacology and Experimental Therapeutics


THE RELATION OF THE CHEMICAL CONSTITUTION OF CERTAIN ORGANIC ARSENICAL COMPOUNDS TO THEIR ACTION ON THE OPTIC TRACT

A. G. YOUNG 1 and A. S. LOEVENHART 1

1 From the Pharmacological Laboratory of the University of Wisconsin

Among the compounds studied by us it was found that those organic arsenicals with an amino group or a substituted amino group in the para position to the arsenic produced optic lesions in the rabbit.

Organic arsenicals with the amino group or substituted amino group in the ortho or meta position to the arsenic produced no optic lesions in the rabbit.

The above statements hold true for both trivalent and pentavalent compounds. This leads us to conclude that in this particular group of compounds, valence of the arsenic is not the most important factor in the production of the optic lesions. However, the valence of the arsenic in certain instances can modify the intensity of action of a given substance on the optic tract as is shown by a comparison of the effects of N-phenylglycine-p-arsonic acid (no. 7) and arsenophenylglycine (no. 4). The most important factor in the production of optic lesions, therefore, is the presence of an animo group in the compound in the para position to the arsenic.

We have discussed the relation of amblyopia as observed clinically to the optic lesions experimentally produced in rabbits and have discussed the role played by the drug and also the disease process in man.

Submitted on February 4, 1924







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1924 by the American Society for Pharmacology and Experimental Therapeutics.